Riskpilot← Back to searchSign inGet full accessAurora Med Oy
OYDissolvedY-tunnus 2042874-1Laivastokatu 4-B23Medical specialists activities · NACE 8622Est. 20061 employees
Revenue 2024
EUR 52,9M
+12929% vs 2023
EBITDA margin
58.4%
+12563% vs 2023
Equity ratio
73.1%
Financial strength
Net profit 2024
EUR 23,6M
+15768% vs 2023
| Revenue | EUR 52,9M | +12929% |
| EBITDA | EUR 30,9M | +12563% |
| Net profit | EUR 23,6M | +15768% |
| Total assets | EUR 953K | +28% |
| Equity | EUR 696K | +61% |
| Employees | 1 | — |
Legal name
Aurora Med Oy
Y-tunnus number
2042874-1
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
9. kesäkuuta 2006
Share capital
EUR 8 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on lääkäripalvelujen tuottaminen, koulutus ja konsultointi. Yhtiö voi omistaa ja hallita kiinteistöjä, osakkeita ja muita arvopapereita sekä käydä niillä kauppaa.
Address
Laivastokatu 4-B23
Phone
+35809626583
Email
aurora.heickell@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 307 | 368 | 392 | 406 | 52 927 |
| Staff expenses | −49 | −44 | −8 | −8 | −6 894 |
| EBITDA | 169 | 209 | 260 | 244 | 30 931 |
| Depreciation & amort. | — | — | — | −0 | −0 |
| EBIT | 169 | 209 | 260 | 244 | 30 931 |
| Net financials | −18 | −18 | −31 | −19 | −16 |
| Profit before tax | 151 | 191 | 230 | 225 | 23 656 |
| Tax | 34 | 39 | 47 | 76 | 58 |
| Net profit | 117 | 152 | 183 | 149 | 23 599 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 726 | 730 | 664 | 744 | 953 |
| Equity | 281 | 323 | 327 | 431 | 696 |
| Long-term debt | 424 | 363 | 301 | 240 | 184 |
| Short-term debt | 21 | 44 | 35 | 72 | 73 |
| Total debt | 445 | 407 | 336 | 312 | 257 |
EBITDA margin
58.4%
This company
15.8%
Market median
+270% vs market
20202024
Equity ratio
73.1%
This company
38.2%
Market median
+91% vs market
20202024
Return on equity
3391.4%
This company
18.4%
Market median
+18332% vs market
20202024
Net profit margin
44.6%
This company
8.1%
Market median
+451% vs market
20202024
Asset turnover
55.56×
This company
1.12×
Market median
+4861% vs market
20202024
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AA Chief Executive Officer | Chief Executive Officer | 2006 |
HM Deputy Member | Deputy Member | 2023 |
| Former (2) | ||
JS Audit | Audit | 2006 – 2022 |
JT Deputy Member | Deputy Member | 2006 – 2008 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aurora Med Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jukka Sakari Taimi | Audit | 0 companies |
| Aurora Asta Gunilla Heickell | Chief Executive Officer | 0 companies |
| Jukka Tapio Rissanen | Deputy Member | 0 companies |
| Helga Magnolia Aurora Rissanen | Deputy Member | 0 companies |